A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction

AIMS: We investigated the effects of CD34(+) cell therapy in patients with heart failure with preserved ejection fraction (HFpEF). METHODS AND RESULTS: In a prospective pilot study, we enrolled 30 patients with HFpEF. In Phase 1, patients were treated with medical therapy for 6 months. Thereafter, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrtovec, Bojan, Frljak, Sabina, Poglajen, Gregor, Zemljic, Gregor, Cerar, Andraz, Sever, Matjaz, Haddad, Francois, Wu, Joseph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Cell Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540623/
https://www.ncbi.nlm.nih.gov/pubmed/35775390
http://dx.doi.org/10.1002/ejhf.2596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540623/
https://www.ncbi.nlm.nih.gov/pubmed/35775390
http://dx.doi.org/10.1002/ejhf.2596

Ejemplares similares